BCM
UTHR icon

Bridgeway Capital Management’s United Therapeutics UTHR Stock Holding History

Bridgeway Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Hold
2,620
– – 0.03% 655
2026
Q1 		$1.55M Sell
2,620
-1,240
-32% -$618K 0.03% 594
2025
Q4 		$1.88M Buy
+3,860
New +$1.8M 0.04% 556
2018
Q2 		– Sell
-13,600
Closed -$1.53M – 1462
2018
Q1 		$1.53M Sell
13,600
-295,430
-96% -$37.5M 0.02% 684
2017
Q4 		$45.7M Buy
309,030
+4,900
+2% +$623K 0.49% 75
2017
Q3 		$35.6M Sell
304,130
-3,400
-1% -$434K 0.41% 85
2017
Q2 		$39.9M Hold
307,530
– – 0.48% 81
2017
Q1 		$41.6M Buy
307,530
+150,730
+96% +$22.8M 0.5% 72
2016
Q4 		$22.5M Buy
156,800
+124,300
+382% +$15.9M 0.29% 100
2016
Q3 		$3.84M Hold
32,500
– – 0.06% 299
2016
Q2 		$3.44M Hold
32,500
– – 0.05% 322
2016
Q1 		$3.62M Hold
32,500
– – 0.06% 306
2015
Q4 		$5.09M Buy
32,500
+5,900
+22% +$859K 0.09% 210
2015
Q3 		$3.49M Hold
26,600
– – 0.07% 288
2015
Q2 		$4.63M Buy
+26,600
New +$4.79M 0.09% 238
2013
Q4 		– Sell
-40,800
Closed -$3.22M – 1442
2013
Q3 		$3.22M Hold
40,800
– – 0.11% 191
2013
Q2 		$2.69M Buy
+40,800
New +$2.63M 0.11% 229

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bridgeway Capital Management's UTHR Position: Q2 2026 in Review

Bridgeway Capital Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 2,620 shares worth $1.42M. The position accounts for 0.03% of the portfolio, ranked #655.

Bridgeway Capital Management first reported a position in UTHR in Q2 2013 and has held it in 17 quarters since. The position peaked at $45.7M in Q4 2017. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bridgeway Capital Management held 2,620 shares of United Therapeutics worth $1.42M as of Q2 2026.
  • Bridgeway Capital Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.03% of Bridgeway Capital Management's portfolio in Q2 2026, its #655 holding.
  • Bridgeway Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 17 quarters since.
  • Bridgeway Capital Management's United Therapeutics position peaked at $45.7M in Q4 2017.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.